How close are we to personalized pharmacotherapies and innovative technology for type 1 diabetes management?

Expert Opin Pharmacother. 2023 Sep-Dec;24(15):1661-1663. doi: 10.1080/14656566.2023.2241354. Epub 2023 Aug 3.

Authors

Kashif M Munir¹, Stephen N Davis²

Affiliations

¹ Division of Endocrinology, Diabetes, and Nutrition, University of Maryland School of Medicine, Center for Diabetes and Endocrinology, Baltimore, Maryland, USA.
² Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland, USA.

PMID: 37534411
DOI: 10.1080/14656566.2023.2241354

No abstract available

Keywords: Continuous glucose monitoring; hybrid closed loop; insulin pumps; personalized pharmacotherapies; teplizumab; type 1 diabetes.

Publication types

Editorial

MeSH terms

Blood Glucose
Diabetes Mellitus, Type 1* / drug therapy
Humans
Hypoglycemic Agents / therapeutic use
Insulin / therapeutic use
Technology

Substances

Hypoglycemic Agents
Blood Glucose
Insulin